ARTICLE | Clinical News
Heptazyme (LY466700): Began Phase II trial
October 15, 2001 7:00 AM UTC
Ribozyme Pharmaceuticals Inc. (RZYM), Boulder, Colo. Product: Heptazyme (LY466700) Business: Infectious diseases Therapeutic category: Viral replication Target: HCV RNA Description: Chemically synthes...